Subcutaneous Administration of Tocilizumab Is Effective in Myointimal Hyperplasia Remodelling in Refractory Takayasu Arteritis. Reumatismo 2017, 69 (4), 184-188. https://doi.org/10.4081/reumatismo.2017.1013.